tradingkey.logo
tradingkey.logo
Search

Quest Diagnostics Inc

DGX
Add to Watchlist
234.145USD
-1.355-0.57%
Market hours 09/09, 10:18ET
25.99BMarket Cap
25.42P/E TTM

More Details of Quest Diagnostics Inc Company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Quest Diagnostics Inc Profile

Ticker SymbolDGX
Company nameQuest Diagnostics Inc
IPO dateDec 17, 1996
CEODavis (James E)
Number of employees45000
Security typeOrdinary Share
Fiscal year-endDec 17
Address500 Plaza Drive
CitySECAUCUS
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07094
Phone19735202700
Websitehttps://www.questdiagnostics.com/
Ticker SymbolDGX
IPO dateDec 17, 1996
CEODavis (James E)

Company Executives of Quest Diagnostics Inc

Name
Name/Position
Position
Shareholding
Change
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
47.59K
+2.40%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
42.30K
-2.36%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
30.71K
+3.72%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
27.46K
+0.08%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
18.39K
+0.39%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
15.53K
+0.24%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
13.06K
+8.75%
Mr. Mark E. Delaney
Mr. Mark E. Delaney
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
10.34K
-15.15%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
7.72K
+14.79%
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
47.59K
+2.40%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
42.30K
-2.36%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
30.71K
+3.72%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
27.46K
+0.08%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
18.39K
+0.39%

FAQs

Who are the top five shareholders of Quest Diagnostics Inc?

The top five shareholders of Quest Diagnostics Inc are: Ms. Catherine T. (Cathy) Doherty

How many institutions hold shares of Quest Diagnostics Inc (DGX)?

As of 2026Q1, 1896 institutions hold shares of Quest Diagnostics Inc, with a combined market value of approximately 110.61M, accounting for 99.92% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3157069.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.